X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Opens Marginally Up; Telecom & Power Stocks Gain
Fri, 4 Jan 09:30 am | Rini Mehta, TM Team

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 3% while the Hang Seng is up 1.3%. The Shanghai Composite is trading up by 1.3%. Meanwhile, Wall Street plunged on Thursday after slowing US factory activity on the heels of a dire revenue warning from Apple Inc fueled fears of a global economic slowdown.

Back home, India share markets opened flat with a positive bias. The BSE Sensex is trading up by 65 points while the NSE Nifty is trading up by 21 points. The BSE Mid Cap index and BSE Small Cap index opened up by 0.4% & 0.2% respectively.

Sectoral indices have opened the day on a mixed with telecom stocks and power stocks witnessing maximum buying interest. While, IT stocks and energy stocks opened the day in red.

The rupee is currently trading at Rs 69.87 against the US$.

Pharma stocks opened the day on a mixed note with Torrent Pharma & Natco Pharma leading the gainers. As per an article in a leading financial daily, Sun Pharma has completed acquisition of Japan-based Pola Pharma to strengthen its presence in dermatology segment across the globe.

Sun Pharma had entered into a definitive agreement to acquire Pola Pharma in November 2018. Pola Pharma is engaged in research and development, manufacture, sale and distribution of branded, and generic products in Japan.

Pola Pharma's portfolio mainly comprises dermatology products. It has two manufacturing facilities in Saitama with capabilities to manufacture topical products and injectables.

Note that, Sun Pharma had forayed into the Japanese prescription market in 2016 with the acquisition of 14 established prescription brands from Novartis.

--- Advertisement ---
What's Written in This Regulatory Document Could Change The Way You Invest…

An important regulatory document has been shown to indicate stocks that have the potential to boom in a few years.

Most investors have no idea where to find these documents…or how to decipher them.

But we've discovered a way…

The Smart Money Secrets team at Equitymaster has been tracking these hidden documents – and the stocks behind them – for a few years now.

In fact, they've even released a special report with full details on 3 such 'regulation 31' stocks.

Here are the details…
------------------------------

Going forward, whether this acquisition adds sheen to the pharma major will be the key thing to watch out for.

To know more about the company, you can access to Sun Pharma's Q2FY19 result analysis and Sun Pharma's 2018-19 Annual Report Analysis on our website.

Sun Pharma share price opened the day down by 0.4%.

Moving on to the news from bank sector. As per the report by ratings agency ICRA, the ongoing issues with the non-bank lenders will crimp the operating profits of such companies by up to 0.5%.

Reportedly, the decline in profitability will be primarily due to increase in the cost of funds, slowdown in portfolio growth and cost of carrying additional liquidity due to the troubles.

As the going gets tough, all the NBFCs have started building extra liquidity buffers, which will narrow the net interest margins by up to 0.15%, thereby impacting the profitability.

There can also be an impact on asset quality as the small businesses segment, one of the largest customer segments for the NBFCs, will find the going tough, it said, adding the loans against property, commercial vehicle and construction equipment will be the most affected.

It can be noted that the defaults by IL&FS in August last year percolated into concerns on wider NBFC universe.

Companies were dependent on short-term money to fund long-term assets were the ones where the concerns were the highest and witnessed huge corrections in stock prices.

While refusing to help directly, the RBI attributed the stress to troubles on asset liability mismatch. The mutual funds segment was one of the primary suppliers of liquidity and have become wary of exposures.

ICRA said the NBFCs have diversified their borrowing to the banking system which has given Rs 700 billion by September alone to support repayment of the maturing borrowings in the October-December period.

It said the growth rate for retail-focused NBFCs will halve to around 12% for the second half of the fiscal, from the 24-25% in the first half, which will take down the overall credit growth to 16-18% for FY19.

Note that, credit growth in NBFCs has seen robust growth in recent years. From 2013-2017, NBFCs grew by 13% as compared to 5.4% for banks.

Is the NBFC Party in India Coming to an End?

A major reason for this is the gain in market share from public sector banks (PSBs). The recent NPA woes of the PSBs has seen them tighten up their credit lines.

The NBFCs have stepped in, along with private sector banks, to fill this gap.

But the recent liquidity crisis at IL&FS has raised concerns over how long this growth will continue.

Such a liquidity crisis will increase lending costs for NBFCs. Once borrowing costs rise for NBFCs, their profitability is bound to take a hit.

One way to counter that would be to raise their lending rates. But then, it would make them less competitive as compared to banks.

In times like these, we at Equitymaster believe, NBFCs with strong asset liability management will come out stronger. On the other hand, NBFCs with a low capital base will struggle in the upcoming high interest rate period.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Opens Marginally Up; Telecom & Power Stocks Gain". Click here!

  

Stock Market Updates

Sensex Ends Marginally Higher; Automobile and Power Stocks Witness Buying (Today's Market)

Aug 16, 2019 Closing

The BSE Sensex ended the day up by 39 points, while the NSE Nifty closed up by 18 points.

PIDILITE INDUSTRIES at All Time High; BSE FMCG Index Up 0.4% (Today's Market)

Aug 16, 2019 03:34 PM

PIDILITE INDUSTRIES share price has hit an all time high at Rs 1,373 (up 1.7%). The BSE FMCG Index is up by 0.4%. Among the top gainers in the BSE FMCG Index today are PIDILITE INDUSTRIES (up 1.7%) and P&G HYGIENE (up 0.2%). The top losers include AVANTI FEEDS (down 0.1%) and COLGATE (down 0.1%).

APL APOLLO TUBES Surges by 6%; BSE CAPITAL GOODS Index Down 0.1% (Today's Market)

Aug 16, 2019 03:32 PM

APL APOLLO TUBES share price has surged by 6% and its current market price is Rs 1,350. The BSE CAPITAL GOODS is down by 0.1%. The top gainers in the BSE CAPITAL GOODS Index are APL APOLLO TUBES (up 6.4%) and SUZLON ENERGY (up 6.7%). The top losers are LAKSHMI MACHINE (down 0.2%) and HONEYWELL AUTOMATION (down 0.4%).

CANARA BANK Surges by 5%; BSE BANKEX Index Up 0.8% (Today's Market)

Aug 16, 2019 03:30 PM

CANARA BANK share price has surged by 5% and its current market price is Rs 237. The BSE BANKEX is up by 0.8%. The top gainers in the BSE BANKEX Index is CANARA BANK (up 5.2%). The top losers is HDFC BANK (down 0.2%).

ECLERX SERVICES Plunges by 5%; BSE IT Index Down 0.8% (Today's Market)

Aug 16, 2019 03:30 PM

ECLERX SERVICES share price has plunged by 5% and its current market price is Rs 519. The BSE IT is down by 0.8%. The top gainers in the BSE IT Index are FIRSTSOURCE SOL. (up 3.5%) and ORACLE FINANCIAL (up 3.2%). The top losers is ECLERX SERVICES (down 5.5%).

DR. LAL PATHLABS LTD Surges by 7%; BSE HEALTHCARE Index Down 0.3% (Today's Market)

Aug 16, 2019 03:22 PM

DR. LAL PATHLABS LTD share price has surged by 7% and its current market price is Rs 1,201. The BSE HEALTHCARE is down by 0.3%. The top gainers in the BSE HEALTHCARE Index are DR. LAL PATHLABS LTD (up 7.1%) and APOLLO HOSPITALS (up 8.1%). The top losers are STRIDES PHARMA SCIENCE (down 0.1%) and SANOFI INDIA (down 0.2%).

View More Indian Share Market News

Most Popular

7 Stocks to Buy in Today's Difficult Market(The 5 Minute Wrapup)

Aug 5, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

The Perfect Stock in the Rebirth of India(The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

My Top 3 Dividend Millionaire Stocks(Profit Hunter)

Aug 7, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation(The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Aug 16, 2019 (Close)

MARKET STATS